2010 Annual Meeting

Session: Crystallization of Pharmaceutical and Biological Molecules 2: In Honor of the Late Dr. Jeff Wei of Eli Lilly

Additional session to cope with high rate of submissions.

Chair

Griffin, D., Lilly Research Laboratories, Eli Lilly and Company

Co-Chair

Snyder, R. C., Bucknell University

Presentations

08:30 AM

Introductory Remarks

08:35 AM

(141a) A Streamlined Approach to Avoiding Oiling in Crystallization Processes of Api's and Intermediates

09:00 AM

(141b) Crystallization Development of a Pharmaceutical API through Implementation of Real-Time Supersaturation Feedback Control

09:15 AM

(141c) Designing a Reactive Crystallization Process for An Agglomerating API

09:35 AM

(141d) Use of a Crystallization Modifier to Enhance Impurity Rejection in the Crystallization of a Pharmaceutical Intermediate

09:55 AM

(141e) Crystallization Tendency of Amorphous Pharmaceuticals Prepared by Rapid Solvent Evaporation: Classification, Comparison with Undercooled Melts and Interpretation in Terms of Physico-Chemical Drug Compound Characteristics

10:15 AM

(141f) Spiral Growth Model for Organic Crystals of Real Complexity: How to Account for Non-Isotropic Behavior

10:35 AM

(141g) Population Balance Modeling of Morphology Distribution of Asymmetric Crystals